Join to View Full Profile
608 Stanton L Young BlvdOklahoma City, OK 73104
Phone+1 405-271-6060
Fax+1 405-271-7873
Dr. Firestone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Brian Firestone is an ophthalmologist based in Oklahoma City, specializing in ocular oncology. He graduated in 2008 from the University of Oklahoma College of Medicine and completed his internship and residency at Texas A&M College of Medicine-Scott and White Medical Center (Temple). He has expertise in retinoblastoma, cataract surgery, and comprehensive ophthalmology. Dr. Firestone has contributed to several publications, with articles focusing on ocular oncology topics such as intraocular pressure management, iodine-125 LDR brachytherapy, and uveal melanoma management. Some of his work has been cited multiple times in the academic community.
Education & Training
Baylor Scott & White Medical Center - Baylor College of Medicine (Temple)Residency, Ophthalmology, 2009 - 2012- Baylor Scott & White Medical Center - Baylor College of Medicine (Temple)Internship, Internal Medicine, 2008 - 2009
University of Oklahoma College of MedicineClass of 2008
Certifications & Licensure
OK State Medical License 2013 - 2025
PA State Medical License 2012 - 2014
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 1 citationsTreatment of uncontrolled intraocular pressure secondary to uveal melanoma status post plaque radiotherapy with ab interno XEN gel stent implantation.Ben J Harvey, Finny T John, Christian A Leal, Brian K Firestone
American Journal of Ophthalmology Case Reports. 2022-09-01 - Ocular malignancies treated with iodine-125 low dose rate (LDR) brachytherapy at a single high-volume institution: A retrospective review.Zachary Richards, My-Lien Nguyen, Michael Kutteh, Salahuddin Ahmad, Christina Henson
Medical Dosimetry. 2022-05-26 - 9 citationsProspective evaluation of risk-appropriate management of uveal melanoma patients informed by gene expression profiling.Amy C. Schefler, Alison H. Skalet, Scott C N Oliver, John O. Mason, Anthony B. Daniels
Melanoma Management. 2020-03-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
